Viridium Pacific Group (CVE:VIR) Trading 5.6% Higher – Should You Buy?

Viridium Pacific Group Ltd (CVE:VIRGet Free Report) shares were up 5.6% on Friday . The company traded as high as C$0.41 and last traded at C$0.38. Approximately 26,500 shares changed hands during trading, a decline of 71% from the average daily volume of 92,632 shares. The stock had previously closed at C$0.36.

Viridium Pacific Group Stock Up 5.6%

The firm has a market capitalization of C$37.52 million and a price-to-earnings ratio of -2.97. The company’s fifty day moving average is C$0.38 and its two-hundred day moving average is C$0.38.

Viridium Pacific Group Company Profile

(Get Free Report)

Viridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use. Viridium Pacific Group Ltd. is headquartered in Mission, Canada.

Further Reading

Receive News & Ratings for Viridium Pacific Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viridium Pacific Group and related companies with MarketBeat.com's FREE daily email newsletter.